Henry Schein, Inc. (NASDAQ:HSIC) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. The company announced the completion of a $250 million strategic investment by funds ...

That strategy accelerated Henry Schein's growth; last year 33 percent of the company's sales were outside the United States. In November 1995 the company went public on the Nasdaq Stock Market ...

Henry Schein Inc. closed 10.96% short of its 52-week high of $82.49, which the company reached on February 5th.

Henry Schein, the Melville-based distributor of medical supplies worldwide, has acquired C&M Vetlink, an animal health products company in Ireland, the company announced Friday.

MELVILLE, N.Y., May 4, 2018 /PRNewswire/ -- Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental, animal health, and medical ...

MELVILLE, N.Y., March 25, 2025--Henry Schein, Inc. (Nasdaq: HSIC) will showcase a selection of its comprehensive business and practice solutions, and provide perspectives on the future of ...

Henry Schein is a medical distributor mostly distributing dental supplies and animal health products. The company is currently facing a FTC investigation, but also has a wide moat protecting its ...

MELVILLE, N.Y., Feb. 19, 2018 /PRNewswire/ -- Henry Schein Dental, the U.S. dental business of Henry Schein, Inc., today announced the lineup of practice solutions and presentations taking place ...

Revenue Growth: Henry Schein displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 1.16%. This indicates a notable increase ...

The Company's sales reached $12.3 billion in 2023, and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

Company Logo Photo: Terrence Horan. Shares of Henry Schein Inc. HSIC rallied 2.08% to $71.54 Thursday, on what proved to be an all-around positive trading session for the stock market, ...

With its stock down 8.4% over the past month, it is easy to disregard Henry Schein (NASDAQ:HSIC). It seems that the market might have completely ignored the positive aspects of the company's ...